Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
Clinical trial NCT06207656 · RECRUITING
Trial details
- NCT number
- NCT06207656
- Sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-16
- Primary completion
- 2029-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.